Trinity Biotech (TRIB) Inventory Average (2009 - 2025)

Trinity Biotech (TRIB) has reported Inventory Average for 17 consecutive years, with $19.5 million the latest figure, recorded in Q4 2025.

• Quarterly Inventory Average fell 5.39% year-over-year to $19.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.5 million (down 5.39% YoY) and the FY2025 annual result came in at $19.1 million, up 86.04% from the prior year.
• Inventory Average eased to $19.5 million in Q4 2025 per TRIB's latest filing, from $19.8 million in the prior quarter.
• Over the last five years, Inventory Average for TRIB reached as high as $36.1 million in Q2 2021 and fell as low as $11.0 million in Q4 2023.
• A 5-year average of $24.2 million and a median of $22.6 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average sank 52.15% — and 2024, when it soared 86.83%.
• Year by year, Inventory Average stood at $30.6 million in 2021, then slipped by 24.79% to $23.0 million in 2022, then plunged by 52.15% to $11.0 million in 2023, then soared by 86.83% to $20.6 million in 2024, then decreased by 5.39% to $19.5 million in 2025.
• According to Business Quant data, Inventory Average over the past three periods registered $19.5 million, $19.8 million, and $20.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.